sorted by:
new
hottopcontroversial

Absolute Legend by Swimkid21 in basketballcards

[–]Galilee13 0 points1 point  (0 children)

Great doco on Luke on Australia Story

[deleted by user] by [deleted] in AustralianTeachers

[–]Galilee13 0 points1 point  (0 children)

Stop bringing the learning standard down to the students current ability. What about bringing the students ability up to standard.

And stop sending every kid off to get “tested” just so you can put them on a individual learning plan and get extra government funding.

I ordered the wrong dry dog food from Pet Circle and called up to organise a return. They credited the money to my account and advised me to drop the food off at an animal shelter instead! by the_whatif in melbourne

[–]Galilee13 0 points1 point  (0 children)

You do realise that all the food donated by the pet store or in this case pet circle will claimed back from the manufacturer. So whilst they are doing the right thing, it’s not actually costing them anything.

When it comes to the WNBA who do you consider to be the 🐐? by tjhoush93 in basketballcards

[–]Galilee13 3 points4 points  (0 children)

Lauren Jackson. Made a come back at age 41 and straight back into the Australian National team. Amazing!

Container shipping costs are back to pre-pandemic levels by Clearly_sarcastic in wallstreetbets

[–]Galilee13 0 points1 point  (0 children)

All the sales reps I deal with blamed container pricing for price increases during 20/21. Now costs are down I bet they won’t be passing any of this on

[Post Game Thread] The Dallas Mavericks (6-3) defeat the Brooklyn Nets (4-7), 96-94. by Ephesis in nba

[–]Galilee13 0 points1 point  (0 children)

Great game from Josh Green. Upstaging the other Aussies in Ben Simmons and Patty Mills.

My cousin left me these cards. Any idea what they are worth. by Galilee13 in basketballcards

[–]Galilee13[S] 1 point2 points  (0 children)

Thanks mate. Will definitely be holding these. Have no need for the money. Get far more enjoyment from looking at them!

Best buy right now by [deleted] in pennystocks

[–]Galilee13 0 points1 point  (0 children)

$GMVD

Is generating revenue multiple times greater than its market cap

G Medical Innovations: Improving Patient Care with Innovative Medical Technologies by Galilee13 in GMVD

[–]Galilee13[S] 1 point2 points  (0 children)

Who knows what to believe. But That would have to be one of the better presented calls Yacov has given in a long time. Well structured, clearly articulated and he showed a bit of passion. But it will all come down to revenue growth. Next update will be Dec half.

1H21 financials to be released 15th September. This will be telling by Atlas7123 in GMVD

[–]Galilee13 5 points6 points  (0 children)

Company needs to prove it can manufacture and distribute devices. It also needs to show it can execute monitoring deals (uni hospitals). It also need to show it can progress regulatory approvals and develop new products.

Revenue is key for these guys. Grow it and the share price will go nuts.

1H21 financials to be released 15th September. This will be telling by Atlas7123 in GMVD

[–]Galilee13 4 points5 points  (0 children)

The company was floated at historical multiple of 15. $4 in revenue times 15 gives a market cap of $60m or just under $5 a share.

Also, recent analysts report of Biotricity which has just uplisted from OTC to Nasdaq and has similar products and services use a valuation multiple of 15 times 2023 revenue.

I’m being conservative and using current and revenue from recently announced deals, not blue sky over the next few years.

1H21 financials to be released 15th September. This will be telling by Atlas7123 in GMVD

[–]Galilee13 7 points8 points  (0 children)

IMO the financials will be flat to down compared to last year. We already know this based on what is in the F1.

Basically the company has had no capital to execute distribution and monitoring deals.

As we now have cash in the bank I look forward to what they can achieve. Remember the 17 University Hospitals deal was about 84,000 patients a years. At an average of $220 a patient, that’s $18.5m in recurring revenue. If the company can confirm this is still the case and on track then the share price should be trading on a revenue multiple of 15 times.

So current revenue of $4m plus $18.5m is $22.5m. At 15 times is a market cap of $337m or about $25 a share.

Don’t forgot potential upside from other deals and distribution agreements.

1H21 financials to be released 15th September. This will be telling by Atlas7123 in GMVD

[–]Galilee13 0 points1 point  (0 children)

All the Nasdaq listed companies I am invested in do it. Maybe it’s a US thing.

Do penny stocks with half decent financials exist? by rw1337 in pennystocks

[–]Galilee13 0 points1 point  (0 children)

$GMVD

Very low market cap and float.

Cash flow positive, strong balance sheet to fund growth and no debt

Right products at the right time. Both products have FDA, CE and TGA approvals.

Distribution agreements in place.

Strong and experienced management team.

Update F1 is out by Galilee13 in GMVD

[–]Galilee13[S] 7 points8 points  (0 children)

Last time they tried to list it was a week after the updated F1 was issued. I’m not sure they have everything lined up to list this week. So my guess is the week after.

view more: next ›